Mutational inhibition of c-Myb or p300 ameliorates treatment-induced thrombocytopenia. [electronic resource]
Producer: 20090616Description: 5599-604 p. digitalISSN:- 1528-0020
- Animals
- Antineoplastic Agents -- adverse effects
- Bone Marrow Transplantation -- rehabilitation
- Cells, Cultured
- Cytoprotection -- drug effects
- Down-Regulation -- genetics
- E1A-Associated p300 Protein -- genetics
- Fluorouracil -- pharmacology
- Genes, myb
- Mice
- Mice, Transgenic
- Mutation -- physiology
- Neoplasms -- drug therapy
- Platelet Aggregation Inhibitors -- pharmacology
- Receptors, Thrombopoietin -- genetics
- Thrombocytopenia -- chemically induced
- bcl-X Protein -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.